SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001062822-22-000033
Filing Date
2022-08-02
Accepted
2022-08-02 16:07:28
Documents
13
Period of Report
2022-08-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lxrx-20220802.htm   iXBRL 8-K 32131
2 EX-99.1 pressreleaseearnings08-02x.htm EX-99.1 58585
  Complete submission text file 0001062822-22-000033.txt   233975

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lxrx-20220802.xsd EX-101.SCH 1893
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lxrx-20220802_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lxrx-20220802_pre.xml EX-101.PRE 12502
7 EXTRACTED XBRL INSTANCE DOCUMENT lxrx-20220802_htm.xml XML 10599
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

IRS No.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 221128708
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences